"10.1371_journal.pone.0094355","plos one","2014-04-23T00:00:00Z","Chad E Mire; Joan B Geisbert; Krystle N Agans; Benjamin A Satterfield; Krista M Versteeg; Elizabeth A Fritz; Heinz Feldmann; Lisa E Hensley; Thomas W Geisbert","Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America; Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America","Conceived and designed the experiments: CEM LEH TWG. Performed the experiments: CEM JBG KNA BAS KMV EAF TWG. Analyzed the data: CEM JBG KNA BAS KMV EAF HF LEH TWG. Contributed reagents/materials/analysis tools: CEM HF LEH TWG. Wrote the paper: CEM HF TWG.","CEM, JBG, KNA, BAS, KMV, EAF, and LEH have declared that no competing interests exist. TWG and HF claim intellectual property regarding VSV-based vaccines for the prevention and treatment of filovirus infections. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","04","Chad E Mire","CEM",9,FALSE,3,7,9,3,TRUE,TRUE,FALSE,0,NA,FALSE
